Claret Asset Management Corp - REDHILL BIOPHARMA LTD ownership

REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 56 filers reported holding REDHILL BIOPHARMA LTD in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
Claret Asset Management Corp ownership history of REDHILL BIOPHARMA LTD
ValueSharesWeighting
Q4 2022$32
-99.9%
228,430
+139.4%
0.01%
-36.4%
Q3 2022$48,000
-42.2%
95,4300.0%0.01%
-38.9%
Q2 2022$83,000
-65.4%
95,4300.0%0.02%
-60.9%
Q1 2022$240,000
-2.4%
95,4300.0%0.05%
+2.2%
Q4 2021$246,000
-14.3%
95,430
+52.1%
0.04%
-8.2%
Q3 2021$287,000
-24.1%
62,730
+14.1%
0.05%
-21.0%
Q2 2021$378,000
-6.0%
54,9720.0%0.06%
-17.3%
Q1 2021$402,000
-9.5%
54,9720.0%0.08%
-14.8%
Q4 2020$444,000
-3.5%
54,972
+22.2%
0.09%
-13.7%
Q3 2020$460,000
+52.8%
44,9720.0%0.10%
+43.7%
Q2 2020$301,000
-5.0%
44,972
-35.7%
0.07%
-20.2%
Q1 2020$317,000
-30.5%
69,972
-6.8%
0.09%
+1.1%
Q4 2019$456,000
-13.8%
75,1020.0%0.09%
-19.3%
Q3 2019$529,000
+32.2%
75,102
+22.1%
0.11%
+31.3%
Q2 2019$400,000
-28.7%
61,502
-8.9%
0.08%
-25.9%
Q1 2019$561,000
+49.6%
67,5220.0%0.11%
+34.9%
Q4 2018$375,000
-10.7%
67,522
+42.1%
0.08%
+2.5%
Q3 2018$420,000
+3.7%
47,5220.0%0.08%
-2.4%
Q2 2018$405,000
+64.6%
47,5220.0%0.08%
+48.2%
Q1 2018$246,000
+12.3%
47,522
+11.8%
0.06%
+16.7%
Q4 2017$219,00042,5220.05%
Other shareholders
REDHILL BIOPHARMA LTD shareholders Q4 2021
NameSharesValueWeighting ↓
683 Capital Management, LLC 1,034,650$6,280,0000.72%
Ibex Investors LLC 5,260,185$31,929,0000.20%
DISCIPLINED GROWTH INVESTORS INC /MN 1,852,362$11,244,0000.18%
GAGNON SECURITIES LLC 112,572$683,0000.15%
Claret Asset Management Corp 75,102$456,0000.09%
IRONWOOD INVESTMENT MANAGEMENT LLC 18,147$110,0000.08%
SANDERS MORRIS HARRIS LLC 47,660$289,0000.07%
Kepos Capital LP 108,000$656,0000.06%
Migdal Insurance & Financial Holdings Ltd. 389,914$2,367,0000.05%
Sowell Financial Services LLC 34,790$211,0000.02%
View complete list of REDHILL BIOPHARMA LTD shareholders